Covid-19: The High Health Authority gives the green light to three new vaccines adapted to the Omicron variant – France Bleu

Covid-19: The High Health Authority gives the green light to three new vaccines adapted to the Omicron variant – France Bleu

The High Authority for Healthcare approved three Covid vaccines adapted by Omicron for a new vaccination campaign planned for this fall and linked to the flu campaign, she announced in a press release on Tuesday.

Booster dose offered to at-risk individuals and caregivers

This new boost will be recommended to people at risk of severe form, their families and carers. The HAS recommends “indifferently one of three bivalent vaccines”: two developed by Pfizer/BioNTech and the third by Moderna. All three have recently been validated by the European Medicines Agency.

“Based on the available data and in an epidemic context marked by the majority circulation of the BA.5 subvariant”, HAS recommends that it is “best” to use one of these vaccines, all for messenger RNA, for a new autumn strengthening dose. This recommendation applies regardless of the Covid vaccine that person was originally given.

Vaccines that are developed for new strains of viruses, such as influenza

Like seasonal flu vaccines, which are updated each year to account for the viruses most likely to circulate during the winter, bivalent mRNA vaccines are not new vaccines, but vaccines adapted to circulating strains.”emphasizes HAS in its press release.

At the same time, HAS maintains its recommendation combine the Covid-19 vaccination reminder campaign with the flu vaccination, which will start on the 18th. A simultaneous injection or the same day of both vaccines is possible, he recalls.

Author Image
adel

Leave a Reply

Your email address will not be published.